CytoChip

Welcome to Cysmic, where cutting-edge innovation meets biomedical excellence. We are dedicated to revolutionizing the field of blood testing and hematological analysis through the development of state-of-the-art microfluidic devices in combination with artificial intelligence (AI) approaches. Our mission is to empower healthcare professionals and patients alike with accurate, efficient, and accessible diagnostic tools that can transform the way we understand and manage human health. At Cysmic, we recognize the critical role that blood analysis plays in healthcare.

Our main products, currently including chemistry analyzer , are crucial for clinical decision-making and treatment pathways, and the immunoassay analyzer and the hematology analyzer are expected to be launched soon. With our strengths in microfluidics technology, we are well positioned to provide affordable IVD tests at the finger of users. We are sincerely looking forward to cooperating with partners who pay close attention to POCT diagnostics, pushing the boundaries of what’s possible in healthcare and helping to improve people’s lives around the world. Currently, MNCHIP keeps researching and developing core technologies, cutting costs, innovating and producing newer and better medical device products for the market. Same in performance while different is size, screen and the number of throughput, Pointcare and Celecare are able to satisfy different medical settings and various medical demands. Established in 2010, MNCHIP is a leading supplier of a full range of in vitro diagnostic equipment. By constantly bringing breakthrough innovations to market, MNCHIP enables healthcare professionals to deliver high-quality medical devices with affordable pricing, serving patients of different income brackets. We will continue to build on our strength to help fight the lack of quality diagnostics devices, empowering patients to develop health awareness as early as possible, thereby reducing healthcare spending and turning to healthier lifestyle.

BioChip Labs is now a registered CLIA certified laboratory. Through extensive experience and broad expertise, we always offer the highest quality. We answer all emails and requests as they come in. Biochip Labs offers over ten types of laboratory tests for people with Sickle Cell Anemia.

We developed a proprietary workflow to rapidly scan blood samples for trillions of exosomes individually to identify and interpret organ-specific exosome populations. We are in the pre-commercial stage with our exosome-based assays for pancreatic cancer and traumatic brain injury, and indevelopment – under commercial sponsorship – with an innovative lung cancer diagnosis and therapy response signature panel. We are exploring multiple disease areas, and 8 peer-reviewed publications provide proof-of-concept validation in over 350 human clinical samples. Chip Diagnostics is commercializing an innovative hardware and data/AI informatics platform, used to develop novel, exosome-based biomarker signatures for early disease diagnostics and therapy management.

Ever since our establishment in 2009, MiCo BioMed has been committed to improving and saving lives by offering innovative IVD technologies in clinical chemistry, immunoassay and molecular diagnostics, and to developing Lab-on-a-Chip based point-of-care testing encompasses any tests that are performed at or near a patient and at the site where care or treatment is provided. Our proven Optimiser™ microfluidic platform is already commercially offered to the life science market. It provides users unheard of enhancements in automation workflow, and improved assay throughput.

On-chip Biotechnologies, incorporated in 2005, is the first company in the world to launch a microfluidic chip-based cell sorter on the market. Our microfluidic chip-based cell sorter, On-chip Sort, designed and manufactured in Japan, uses a disposable microfluidic chip as the core of its technology. Our microfluidic chips are manufactured with Japan’s outstanding high-precision plastic injection molding technology. Therefore, as a prevention for post-sorting cell changes with conventional cell sorter, we developed On-chip Sort. On-chip Biotechnologies is the first company in the world to launch a microfluidic chip-based cell sorter on the market.Our microfluidic chip-based cell sorter, On-chip Sort, designed and manufactured in Japan, uses a disposable microfluidic chip as the core of its technology.Our mission is to assist researchers in accelerating the world’s new discoveries in life science, drug development and diagnostics with On-chip Sort. On-chip products delivered in University of Birmingham on February 13. The use of the disposable microfluidic chip as the core of On-chip Sort realizes great benefits over conventional cell sorters. On-chip Biotechnologies currently offer two instruments: On-chip Sort (cell sorter) and On-chip SPiS (single cell dispenser).